Medtronic
MiniMed 770G Insulin Pump System with Smartphone Connectivity Receives FDA Approval
MiniMed™ 770G hybrid closed loop system expands the benefits of hybrid closed loop therapy to younger children living with type 1 diabetes and makes it easier to access and share real-time CGM and pump data.
Medtronic Begins Post-Market, Real-World Study of the InterStim™ Micro System
“SNM therapy is already proven to be safe and effective, but we expect the ELITE study to definitively reinforce established SNM evidence in patients implanted with the new InterStim Micro system,” said Victor Nitti, M.D., the Shlomo Raz Chair in urology, professor of urology and obstetrics and gynecology, and chief and fellowship director of Female Pelvic Medicine and Reconstructive Surgery at the David Geffen School of Medicine at UCLA.
InterStim™ Micro Neurostimulator and InterStim™ SureScan™ MRI Leads Receive FDA Approval
InterStim™ Micro Neurostimulator and InterStim™ SureScan™ MRI Leads make Medtronic the only company to offer patients and physicians a choice in SNM systems to match their preferences, lifestyle and treatment goals.
LINQ II Insertable Cardiac Monitor Receives FDA Clearance and CE Mark
LINQ II™ insertable cardiac monitor is a small (one-third the size of a AAA battery), wireless ICM for patients with abnormal heart rhythms who experience infrequent symptoms including dizziness, palpitations, syncope (fainting) and chest pain, thereby requiring long-term monitoring or ongoing management.
Medtronic Introduces MiniMed™ Mio™ Advance Infusion Set Enabling Fewer Insertion Steps for People with Diabetes in the U.S.
The MiniMed™ Mio™ Advance infusion set s inserted in only four steps. Individuals simply peel, pinch, place, and press to insert the infusion set.
Percept PC Deep Brain Stimulation System with BrainSense Technology Receives FDA Approval
BrainSense™ technology makes Percept the first and only DBS neurostimulation system with the ability to chronically capture and record brain signals while delivering therapy to patients with neurologic disorders associated with Parkinson’s disease, essential tremor, dystonia, epilepsy or obsessive-compulsive disorder.
Medtronic Evolut TAVI System Receives Expanded Indication in Europe to Treat Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality
The Evolut TAVI System, with its excellent hemodynamics, allows for improved heart function that helps many patients resume their pre-aortic stenosis activity.
ABRE Clinical Study Meets Primary Safety and Effectiveness Endpoints
The ABRE Study is a prospective, interventional, single-arm, multi-center, worldwide study, which included 200 subjects with symptomatic iliofemoral venous outflow obstruction from 24 sites throughout the U.S. and Europe.
Medtronic Micra™ AV Receives CE Mark
Micra AV is indicated for the treatment of patients with AV block, a condition in which the electrical signals between the chambers of the heart (the atria and the ventricle) are impaired.
